Anticoagulant Reversal in Stroke: Best Practices for Successful Outcomes

This program will focus on why clinicians must have a greater recognition of the risks and potential consequences of anticoagulant reversal in patients receiving anticoagulant therapies and the treatment algorithms for initiating reversal therapy in the diverse and expanding patient populations who use anticoagulants.

There is a need for clinician awareness of the importance of anticoagulant reversal therapies and situations that warrant the administration of such therapies. Stroke specialists must be able to identify appropriate candidates for anticoagulant reversal in persons suffering an ischemic or hemorrhagic stroke, as well as how to select the most appropriate reversal therapy on an individualized patient basis. In particular, clinicians must have a greater recognition of the risks and potential consequences of anticoagulant reversal in patients receivingvanticoagulant therapies and the treatment algorithms for initiating reversal therapy in the diverse and expanding patient populations who use anticoagulants. The growing reliance on non-vitamin K direct oral anticoagulants (DOACs) instead of traditional oral vitamin K anticoagulants (VKAs) necessitates knowledge regarding DOAC-specific reversal agents, including their benefits, risks, timing, dosing, and appropriate indications in order to optimize outcomes.

Login to your Account